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Abstract
The cardiac conduction system (CCS) consists of distinctive components that
initiate and conduct the electrical impulse required for the coordinated contrac-
tion of the cardiac chambers. The development of the CCS involves complex
regulatory networks of transcription factors that act in stage, tissue and dose-
dependent manners. As disrupted function or expression of these factors may
lead to disorders in the development or function of components of the CCS
associated with heart failure and sudden death, it is crucial to understand the
molecular and cellular mechanisms underlying their complex regulation. Here,
we discuss the regulation of genes driving CCS-specific gene expression and
demonstrate the complexity of the mechanisms governing their regulatory
networks. The three-dimensional conformation of chromatin has recently been
recognized as an important regulatory layer, shaping the genome in regulatory
domains and physically wiring gene promoters to their regulatory sequences.
Knowledge of the mechanisms by which distal-acting regulatory sequences
exert their function to drive tissue-specific gene expression and understanding
how the three-dimensional chromatin landscape is involved in this regulation
will increase our understanding of how disease-associated genomic variation
affects the function of such sequences.
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The cardiac conduction system (CCS) initiates and propagates the electrical
impulse that is required for the rhythmic and synchronized contraction of the
heart. The impulse initiates in the sinoatrial node (SAN) and is rapidly propagated
through the atria, thereby activating the contraction of the atrial myocardium. The
impulse is then propagated through the atrioventricular node (AVN), the only
electrical connection between the atria and ventricles. The AVN delays conduction
of the impulse, allowing for the atrial contraction and ventricular filling to complete
before the ventricles contract. Further propagation of the impulse to the fast-
conducting atrioventricular bundle (AVB), bundle branches (BBs) and Purkinje
network causes the depolarization of the ventricular myocardium, leading to ven-
tricular contraction. The development of the CCS is regulated by transcription
factors that act in strictly stage, tissue and dose-dependent manners [1, 2]. A
disruption in the function or expression of these factors could lead to disorders in
the development or function of the CCS that can lead to lethal arrhythmias and heart
failure. Knowledge of the mechanisms underlying regulation of genes involved in
CCS development is therefore crucial.
38.2 Genetic Pathways Controlling SAN and AVC Development
The heart is the first organ to form during embryonic development and starts as a
primitive, linear tube with the inflow region at the caudal side and the outflow
region at the cranial side. The slow conductive properties of the embryonic muscle
cells within the primitive tube at this stage and dominant pacemaker activity at the
caudal end cause a slow peristaltic pattern of contraction along the tube to propa-
gate the blood. At this stage, the entire sinus venosus acts as pacemaker,
characterized by the expression of the pacemaker channel Hcn4, a member of the
family of channels responsible for the hyperpolarization-activated current if that is
crucial for the pacemaker potential [3, 4]. The heart tube elongates by the addition
of rapidly proliferating progenitor cells that differentiate to cardiac muscle. This
implies that cells added to the inflow tract will acquire dominant pacemaker
activity. With further development, specific regions in the heart tube start to divide
rapidly and activate a working myocardial gene program, resulting in the balloon-
ing of the primitive atrium and ventricle. Concomitant with the ballooning of the
primitive atria is the formation of the sinus venosus including the SAN. Dominant
pacemaker activity will gradually be confined to the SAN at the junction of the
sinus venosus and atrium.
The transcriptional activator Tbx5 is required for the sinus venosus expression of
Shox2 [5], a homeobox transcription factor necessary for SAN formation and
function [6, 7]. Shox2 represses cardiac homeobox transcription factor Nkx2-5
[6]. In the chambers, Nkx2-5 activates chamber-specific genes including Nppa
and high-conductance gap junction subunit-encoding genes Gja5 (Cx40) and Gja1
(Cx43), whereas it represses SAN/CCS-specific genesHcn4 and T-box transcription
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factor Tbx3 [8]. Tbx3 is required for the formation of the SAN by directly repressing
atrial myocardial genes Gja5, Gja1 and Nppa to prevent atrialization of the SAN
and indirectly activating Hcn4 and other SAN genes [9, 10].
During ballooning of the primitive cardiac chambers, the region in between the
atria and ventricles does not proliferate and forms a constriction, the atrioventricu-
lar canal (AVC). Bmp2 expression in the AVC activates the expression of Tbx3 and
Tbx2 [11]. Together with Msx2, these T-box factors repress the working
myocardial gene program in the AVC and AVC-derived AVN [12, 13] and stimu-
late the pacemaker gene program and the program required for the formation of the
AV cushions. Within the AVC, Tbx2 and Tbx3 interact with Nkx2-5 to repress
genes that are activated by Nkx2-5 and Tbx5 in the working myocardium of the
atria and ventricles [14–16]. Tbx2 and Tbx3 thus suppress working myocardial
differentiation of the AVC, thereby causing the retention of the primitive phenotype
of slow conduction and low rates of proliferation, providing a primitive morpho-
logical and functional constriction in between the atrial and ventricular chambers.
Other factors that regulate the formation of the AVC and its border with the
chamber myocardium include Wnts, acting upstream of Bmp2; Hey1 and Hey2,
Notch target genes expressed in the chambers that suppress Tbx2 [17]; Tbx20,
which represses BMP-mediated activation of Tbx2 in the chambers [18]; and
Gata4/6, which act in complex with Smads and histone acetyltransferases (HATs)
to activate AVC-specific enhancers in the AVC and with histone deacetylases
(HDACs) and Hey1/2 to suppress these enhancers in the chambers [19]. The
resulting pattern of conduction—fast in the atria, slow in the AVC and fast in the
ventricles—results in the alternating contraction pattern of the chambers and an
ECG that resembles the adult ECG (Fig. 38.1a).
38.3 Transcriptional Regulation of CCS Genes
Although the expression patterns and functions of genes involved in the develop-
ment of the cardiac conduction system are relatively well studied, little is known
about the molecular mechanisms underlying their regulation of expression. Tissue-
specific gene expression often involves long-range regulatory elements, such as
enhancers, which dictate the strictly time-, tissue- and dosage-dependent expression
of their target genes. The identification and function of such enhancers is therefore
highly relevant to fully understand the complex regulatory networks in CCS
formation. However, to date only few studies have been carried out investigating
in depth the regulation of genes driving CCS development.
The T-box transcription factor Tbx5 plays indispensable roles in the early
patterning of the heart and CCS and is involved in limb development [15, 20,
21]. Mutations in TBX5 are associated with Holt-Oram syndrome, a developmental
disorder characterized by hand-heart defects [22, 23]. Using modified bacterial
artificial chromosomes (BACs), the regulatory landscape of the TBX5 locus was
determined, and within this landscape, multiple cardiac-specific enhancers were
identified by utilizing multiple genome-wide ChIP-seq datasets and evolutionary
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conservation. These enhancers were shown to recapitulate part of the TBX5
expression pattern in the heart, but interestingly, none of these fragments drove
reporter expression in the limbs, suggesting that the cis-regulation of TBX5 in the
heart and limbs is compartmentalized [24]. Such knowledge can highly improve the
understanding of the mechanisms underlying the development of congenital heart
diseases by decoupling the heart and hand phenotypes seen with Holt-Oram syn-
drome, thereby presenting more compartmentalized phenotypes compared to












































Fig. 38.1 Schematic overview of cardiac development. (a) The early heart tube has a primitive
phenotype of slow conduction, represented by a sinusoidal ECG. With further development,
regions at the outer curvatures of the primary heart tube expand and obtain a working myocardium
phenotype of fast conduction (grey). The sinus venosus (sv), AVC, outflow tract (oft) and inner
curvatures retain their primitive pacemaker-like phenotype and slow conductivity (purple). A
more mature ECG can be derived from these hearts. Eventually, these non-chamber myocardial
regions will give rise to the mature conduction system components. (b) The transcriptional
repressors Tbx2 and Tbx3 compete with the transcriptional activator Tbx5 to regulate their target
genes. In the AVC, expression of chamber myocardium genes like Nppa is actively repressed by
Tbx2 and Tbx3, whereas in the developing chambers Tbx5 activates these genes. Transcriptional
activation in the AVC is regulated by GATA binding site-dependent histone modifications which
render the chromatin more (e.g. HATs) or less (e.g. HDACs) accessible for transcription factors to
bind their target regulatory sequences, resulting in activation or repression of gene expression
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Another example of how enhancer-mediated gene expression is involved in the
tight regulation of the CCS is presented by the transcriptional repressor Id2. This
factor was identified by serial analysis of gene expression (SAGE) as having
CCS-specific expression. Id2 is expressed throughout development in the AVB
and BB and in non-CCS compartments such as the AV endocardial cushions and
valves. The requirement of Id2 for ventricular CCS structure and function was
demonstrated as Id2-deficient mice exhibit structural and functional conduction
system abnormalities, including left bundle branch block. Id2 is cooperatively
regulated by Nkx2-5 and Tbx5 in the developing ventricular conduction system by
binding of both Tbx5 and Nkx2-5 to a 1052 bp fragment of the Id2 promoter.
Mutation of the Tbx5 binding site within this promoter region completely abolished
CCS expression whereas extracardiac expression was unaltered, illustrating the
specificity of this transcriptional mechanism in the coordinated development of
the ventricular conduction system [20].
The hyperpolarization-activated channel HCN4 is required for the generation of
pacemaker action potentials in the embryonic heart. Using a transgenic BAC
approach, it was shown that the regulatory regions sufficient to recapitulate the
endogenous Hcn4 expression pattern in the SAN, AVN, His bundle, bundle
branches and left ventricular Purkinje fibres reside within the region covered by
one bacterial artificial chromosome (BAC) of 200 kbp [25]. Using transgenic
mouse assays, multiple evolutionary conserved cis-acting regulatory sequences
were identified to drive Hcn4 expression in the AV conduction system. One of
these regions drives reporter expression specifically in the non-chamber myocar-
dium in a Mef2c-dependent manner. Furthermore, depletion of histone deacetylases
resulted in ectopic expression of reporter activity in chamber myocardium, reveal-
ing a role for histone modifications in Mef2c-regulated enhancer-mediated expres-
sion of Hcn4 in components of the CCS [26].
More recently, Contactin-2 (Cntn2), a cell adhesion molecule critical for neuro-
nal patterning and ion channel clustering, was described as a marker for the
ventricular conduction system, with expression in the AVB, BBs and Purkinje
fibres. Using a GFP-modified BAC, the boundaries of the regulatory domain
involved in the control of Cntn2 expression were identified, since reporter activity
of the modified BAC completely recapitulates endogenous Cntn2 expression
[27]. Such knowledge facilitates in the identification of single, individual regulatory
elements driving CCS development and will greatly add to our understanding of
how genes involved in the complex development of CCS components are regulated.
Enhancer function is regulated by modifications of specific histone tails that
mark active or poised enhancers. Active enhancers are associated with an open,
accessible chromatin state, whereas poised enhancers are associated with dense,
closed chromatin. Histone modifiers such as histone deactelyases (HDACs), histone
methyltransferases (HMTs) and histone acetyltransferases (HATs) therefore regu-
late the accessibility of long-range regulatory sequences, allowing for the binding
by cell type-specific transcription factors to activate transcription in a
tissue-dependent manner. Specification of the AVC is regulated by Gata4, which
activates AVC enhancers in synergy with Bmp2/Smad signaling to recruit HATs
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such as p300 [19, 28]. This leads to H3K27 acetylation, a marker of active
enhancers. In contrast, in chamber myocardium, Gata4 cooperates with HDACs
and chamber-specific genes Hey1 and Hey2, leading to H3K27 deacetylation and
repression (Fig. 38.1b) [19].
38.4 Common Genomic Variants Influence CCS Function
The importance of the strict regulation of the spatial and temporal expression of
CCS genes is illustrated by findings from recent genome-wide association studies,
which revealed common genomic variation to be associated with conduction
parameters like PR interval and QRS duration. Such variation was identified in
non-coding regions flanking genes encoding ion channels like SCN5A/10A, KCNQ1
and KCNH2 and cardiac transcription factors like NKX2-5, MEIS1 and TBX3/5,
indicating they might affect the function of enhancers controlling the precise
regulation of these genes [29–31]. Tbx5 is broadly expressed and acts as transcrip-
tional activator, inducing transcription of genes involved in cardiac differentiation
[15, 20]. The activity domain of Tbx3 is much more restricted and confined to the
developing and mature CCS, where it acts as a transcriptional repressor, thereby
imposing the pacemaker phenotype on cells within its expression domain
[10, 32]. Tbx3 and Tbx5 both recognize the same regulatory sequences [33],
suggesting that these factors compete for binding and implicating a fine balance
between activation and repression of CS genes by these factors. The precise
regulation of transcription and activity of both factors is therefore crucial for proper
CCS patterning, and minor changes in regulatory elements controlling the regula-
tion of expression of these factors could thus potentially have large consequences
for CCS function and development. Knowledge of the mechanisms by which such
developmental genes are regulated to exert their spatio-temporal transcriptional
activity is therefore crucial in the understanding of how variation identified by
GWAS influences development.
38.5 3D Architecture Regulates Transcription
Physical enhancer-promoter contacts are a requirement for enhancer-mediated cell
type-specific gene expression, and as such, the three-dimensional topology of
chromatin plays an indispensable role in gene regulation by physically wiring
long-range regulatory sequences with their target promoters [34]. Several protein
complexes, including CTCF, cohesin and mediator, have been proposed to be
involved in the organization of these contacts [35]. Furthermore, recent data
suggest that such genomic structural organizers not only mediate single enhancer-
promoter contacts but also mediate the organization of the genome in relatively
cell-type invariant topologically associated domains (TADs) within which
sequences particularly contact each other. Genes located within the same TAD
exhibit greater expression correlation than genes located in distinct ones,
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suggesting that such domains may act as a backbone for tissue-specific regulatory
contacts [36]. The recent emergence of techniques aimed at capturing the 3D
conformation of genomic loci [37] therefore provides valuable tools to elucidate
regulatory mechanisms on the chromatin level.
38.6 Regulation of Tbx3 by a Large Regulatory Domain
The evolutionary conserved Tbx3/5 genomic locus is one of the few genomic loci of
which the 3D architecture has been studied and reveals an example of the complex-
ity of gene regulation on the level of chromatin topology. Tbx3 and Tbx5 form an
evolutionary conserved gene cluster derived from a primordial T-box gene [38]
and, as mentioned above, play crucial roles in the formation and function of the
cardiac conduction system. Using circular chromosome conformation capture
sequencing (4C-seq), which captures all the genomic regions in close proximity
to a chosen point of view [39], the 3D architecture of the Tbx3/5 locus was probed,
and genomic regions contacting Tbx3 or Tbx5 were identified in different tissues
(Fig. 38.2a). Interestingly, these data revealed that the regulatory landscape is in a
preformed conformation that is similar in embryonic heart, brain and limb. Rather
than the de novo formation of enhancer-promoter loops upon binding by cell-type
relevant transcription factors to initiate transcription, the locus is in a fixed,
permissive structure in which enhancer-promoter loops are pre-existing
[40]. Such a permissive structure has previously been described for different loci,
including the Hox and Shh gene loci. Long-range enhancer-promoter contacts in
these loci were shown to be irrespective of cell type, revealing a preformed
topology [36, 41]. The permissive, preformed nature of these loci was exemplified
by the fact that even in the absence of a distal-acting Shh enhancer, contacts
between the Shh promoter and the enhancer region still occur [41]. The benefit of
such preformed regulatory landscapes is believed to lie in the ease by which tissue-
specific transcription factors can utilize preformed contacts to target the gene of
interest, involving only slight variations in internal contacts within an otherwise
rigid and conserved structure. In agreement with this, small differences in contact
profiles for the different tissue types were observed in the Tbx3/5 locus despite the
fact that the domain is largely preformed, most probably caused by cell type-
specific transcription factor mediated enhancer activation. Among the multiple
sites contacting Tbx3 in the gene desert upstream of the gene, two evolutionary
conserved enhancers have been identified that also contact each other. They are
bound by cardiac-specific transcription factors Nkx2-5, Gata4, Tbx5 and Tbx3 and
were shown to respond to a BMP-mediated signalling pathway to drive atrioven-
tricular conduction system expression of Tbx3 [40].
As mentioned before, Tbx3 and Tbx5 are expressed in overlapping patterns and
have overlapping functions in CCS development. It could therefore be expected that
both genes share common regulatory mechanisms on a genomic level. Studies on
the transcriptional regulation of other clustered developmental genes, like the Irx
and Hox clusters, revealed that regulatory sequences are not uniquely associated
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with single promoters, but rather are shared by multiple genes within the cluster.
Such interplay between multiple enhancers coordinates the strict regulation of their
expression patterns, and it has been proposed that such extensive enhancer sharing
explains the conservation of the genomic organization throughout evolution
[42, 43]. Interestingly, however, Tbx3 and its flanking gene desert form a loop
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Fig. 38.2 The regulatory domains of Tbx3 and Tbx5 are physically separated. (a) Contact profiles
of the Tbx3 and Tbx5 loci as determined by circular chromosome conformation capture (4C) reveal
the genomic regions that physically contact Tbx3 (upper track) or Tbx5 (lower track) in mouse
embryonic heart cells. Red and dark blue depict a high contact frequency, whereas light blue and
grey depict a low contact frequency. The contact profiles of Tbx3 and Tbx5 hardly overlap,
indicating that both genes do not share regulatory sequences and suggesting that common variants
in humans upstream of TBX3 as identified by GWAS (star) can be exclusively assigned to TBX3
[40]. (b) Model of the 3D conformation of the Tbx3/Tbx5 locus. The regulatory domains of Tbx3
and Tbx5 are physically separated; however, on the protein level, both genes recognize the same
binding sequences and compete with each other to activate or repress their target genes, e.g. Gja5
(Cx40). Despite the strict regulation on the chromatin level, Tbx5 also directly regulates Tbx3 by
binding target sequences to activate transcription in, for example, the SAN
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Genomic regions within the Tbx3 loop solely contact Tbx3 but not Tbx5 and vice
versa, indicating enhancer sharing between these evolutionary conserved clusters is
unlikely to occur [40]. The strict separation of the regulatory landscapes of Tbx3
and Tbx5 is not only cell type-independent, but also evolutionary conserved
between mouse and human. Recent Hi-C data in human fibroblasts [36], revealing
genome-wide contact profiles, reveal a similar separation of the TBX3 and TBX5
regulatory domains with hardly any overlap of the contact profiles. This organiza-
tion of the Tbx3 locus in a ~1 Mb-scale self-regulatory domain corresponds well to
the previously mentioned TADs. These domains are separated by boundary regions
enriched for insulator binding protein CTCF, housekeeping genes, transfer RNA
and short interspersed elements, hampering interactions of sequences within one
TAD with regions exceeding the domain boundaries. Regions located within the
regulatory domain of Tbx3 are thus suggested to exclusively contact Tbx3 and not
Tbx5 and vice versa.
38.7 Assigning Function to Genomic Variation
Understanding the 3D architecture of a genomic locus not only provides insight into
the tight relationship between chromatin topology and the complex regulation of
developmental gene expression, it could also provide valuable clues in the under-
standing of the role of functional variation as identified by genome-wide associa-
tion studies on gene expression. Common genomic variation in the non-coding
region upstream of TBX3 and TBX5 was found to influence PR interval and QRS
duration in humans [29–31]. The fact that the regulatory domains of TBX3 and
TBX5 are strictly separated indicates that the variation found in one of the domains
can be exclusively assigned to its respective gene, facilitating our understanding of
the functional effect of disease-associated variation.
A similar example of how knowledge on the chromatin conformation can
increase our understanding of function of common variants is illustrated by studies
on the SCN5A/SCN10A locus. SCN5A and SCN10A encode sodium channels
important for conduction. GWAS implicated an intronic region in SCN10A as a
major risk region for prolonged QRS duration [30]. The role of SCN10A in cardiac
conduction however was not previously described, whereas mutations in the adja-
cent SCN5A are well established to cause several arrhythmogenic disorders, includ-
ing Brugada and Long QT syndrome [44, 45]. It is therefore possible that the
variation identified within the intron of SCN10A impacts the expression of
SCN5A, rather than or in addition to that of SCN10A. Indeed, probing the 3D
architecture with the promoters of both SCN5A and SCN10A and the site of the
variation in the intron as point of view using 4C-seq revealed that this variant region
contacts the SCN5A promoter and a strong enhancer downstream of SCN5A,
suggesting that it might act as enhancer regulating the expression of SCN5A in
the heart. Transgenic reporter assays revealed that indeed this enhancer is essential
for cardiac Scn5a expression. In humans, the SNP located within the enhancer that
correlates with slowed conduction is associated with lower SCN5A expression
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[46]. Taken together, these results provide another example of how our understand-
ing of the 3D architecture of a genomic locus harbouring functional variation can
facilitate in the assignment of function to such variations, improving our under-
standing of the effect of disease-associated variation.
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